IOTA PHARMACEUTICALS
Iota Pharmaceuticals is a new-style pharmaceutical discovery company. Built around the scientific expertise and industrial experience of its Founders, and leveraged by networked resources, IOTA possesses a wealth of discovery knowledge and experience which we place at your disposal.
IOTA PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.iotapharma.com
Status:
Active
Contact:
+44 (0) 1223 421430
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Content Delivery Network Nginx Google Maps Cloudflare JS CDN JS GoDaddy DNS
Similar Organizations
Pharmaceutical Specialties
Pharmaceutical Specialties is a respected pharmacy specializing in pulmonary medicine.
VDDI Pharmaceuticals
VDDI Pharmaceuticals is an Internet-based pharmaceutical development company
Official Site Inspections
http://www.iotapharma.com
- Host name: 185.165.123.36
- IP address: 185.165.123.36
- Location: Russia
- Latitude: 55.7386
- Longitude: 37.6068
- Timezone: Europe/Moscow
More informations about "Iota Pharmaceuticals"
Iota Pharmaceuticals Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Iota Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Iota Pharmaceuticals - Crunchbase Company Profile & Funding
Iota Pharmaceuticals is a new-style pharmaceutical discovery company. Built around the scientific expertise and industrial experience of its Founders, and leveraged by networked resources, …See details»
IOTA Pharma - Craft
IOTA Pharmaceuticals is a pharmaceutical discovery company. It provides fragment-based drug design, development, and screening services. The company also offers fragment libraries in a …See details»
IOTA Pharmaceuticals - LinkedIn
IOTA is a new-style pharmaceutical discovery company. Built around the scientific expertise and industrial experience of its founders, and leveraged by networked resources, IOTA possesses …See details»
IOTA Pharmaceuticals Ltd - VentureRadar
Syngene (Biocon) India n/a Syngene is an innovation-led contract research, development, and manufacturing organization offering integrated scientific services from early discovery to …See details»
IOTA Pharmaceuticals Ltd - Cambridge, United Kingdom
Feb 22, 2011 iotapharma.com +441223421430. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. IOTA Pharmaceuticals Ltd. St Johns …See details»
IOTA Pharmaceuticals - Overview, News & Similar companies
May 23, 2018 www.iotapharma.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. IOTA and MassGen Hospital Establish PHOENIX, an …See details»
IOTA Pharmaceuticals | Scientist.com
Iotapharma.com: Headquarters: GB Company Type: Small Business (1-10M TTM Revenue) Description Sites IOTA Pharmaceuticals offers virtual screening packages, screening …See details»
News | Astellas Pharma Inc.
TOKYO October 30, 2020 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that it has completed the acquisition of Iota …See details»
David Bailey - Director - IOTA Pharmaceuticals Ltd - LinkedIn
CEO at IOTA Pharmaceuticals · An expert in the areas of genomics, biotechnology and drug discovery, my goal is to develop new tools and technologies for glioblastoma drug discovery …See details»
Astellas Completes Acquisition of iota Biosciences
Oct 30, 2020 1 Press Release Astellas Completes Acquisition of iota Biosciences TOKYO October 30, 2020 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, …See details»
Establishment of IOTA Pharmaceuticals, a new Fragment-based
CAMBRIDGE, England, Sept. 25 /PRNewswire/ -- The formation of a new drug discovery company, IOTA Pharmaceuticals, is announced. Centred on fragment- based drug design, …See details»
IOTA Pharmaceuticals announce the creation of a Glioblastoma …
May 23, 2018 The new bank, announced today, will support and accelerate new research into brain cancer therapy Cambridge-based IOTA Pharmaceuticals Ltd have just announced the …See details»
After R&D tryout, Astellas opts to acquire bioelectronics maker …
Oct 15, 2020 To add a new set of revenue building-blocks, Astellas Pharma has snapped up the bioelectronics developer Iota Biosciences and its ultra-small medical implants in a deal worth …See details»
IOTA Pharmaceuticals Announce the Creation of a Glioblastoma …
CAMBRIDGE, England, May 23, 2018 /PRNewswire/ --. IOTA Pharmaceuticals Ltd today announced the creation of a new resource, the Glioblastoma (GBM) Drug Bank, to accelerate …See details»
News | Astellas Pharma Inc.
Oct 15, 2020 - Accelerate Rx + ® business by acquiring innovative technology for ultra-small implantable medical devices and world-class talent in the bioelectronics field - TOKYO and …See details»
Octapharma - Crunchbase Company Profile & Funding
Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving …See details»
Annual Report - Octapharma AG
Annual Report 2023 Focused. For the Future. In 2023, Octapharma celebrated 40 years of innovation and success since our company was founded in 1983 by two men with a shared …See details»
Building the organisation of tomorrow - Octapharma AG
Feb 19, 2024 The right tools. Octapharma’s drive to introduce simplified processes has been reflected not only in HR, but also in Production and IT. The global IT team introduced its new …See details»
Maria's path to leadership: A story of growth and ... - Octapharma …
Nov 6, 2024 “My journey with Octapharma Stockholm (OAB) began in August 2013,” remembers Maria. Starting out as a Product Manager/Product Responsible in the Production Support …See details»